NVIDIA (NVDA) Gets Buy Rating as AI Data Center Demand Surges Past $50 Billion
NVIDIA Corporation (NASDAQ:NVDA) is one of the 10 AI Stocks on Wall Street's Radar. One of the most notable analyst calls on Tuesday, June 10, was for NVIDIA Corporation (NASDAQ:NVDA). Bank of America reiterated the stock as 'Buy,' stating that data center demand trends remain robust for Nvidia.
'Developing AI infrastructure leveraging local datasets and workforces is a rapidly growing global phenomenon and we expect it to contribute $50bn+ annually or 10%+ of long-term AI addressable market.'
A powerful aerial view of the company's data center, exemplifying the digital services and informatics being offered.
In other latest news, Nvidia Corporation and Hewlett-Packard Enterprise said on Tuesday that they are partnering with the Leibniz Supercomputing Centre to build a new supercomputer using Nvidia's next-generation chips.
While we acknowledge the potential of NVDA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: and
Disclosure: None.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Israel launches 'preemptive' strikes on Iran
Israel carried out "preemptive" strikes against Iran on Friday, targeting its nuclear plant and military sites, after US President Donald Trump warned of a possible "massive conflict" in the region. Explosions were heard Friday morning in the Iranian capital, state TV reported, adding that Iran's air defence were at "100 percent operational capacity". Israel declared a state of emergency, with Defence Minister Israel Katz saying that retaliatory action from Tehran was possible following the operation. "Following the State of Israel's preemptive strike against Iran, a missile and drone attack against the State of Israel and its civilian population is expected in the immediate future," Katz said. Oil prices surged as much as 6 percent on the strikes, which came after Trump warned of a possible Iranian attack and said the US was drawing down staff in the region. "I don't want to say imminent, but it looks like it's something that could very well happen," Trump told reporters at the White House Thursday when asked if an Israeli attack loomed. Trump said he believed a "pretty good" deal on Iran's nuclear programme was "fairly close", but said that an Israeli attack on its arch foe could wreck the chances of an agreement. The US leader did not disclose the details of a conversation on Monday with Israeli Prime Minister Benjamin Netanyahu, but said: "I don't want them going in, because I think it would blow it." Trump quickly added: "Might help it actually, but it also could blow it." A US official said there had been no US involvement in the Israeli strikes on Iran. -- 'Extremist' -- The United States on Wednesday said it was reducing embassy staff in Iraq -- long a zone of proxy conflict with Iran. Israel, which counts on US military and diplomatic support, sees the cleric-run state in Tehran as an existential threat and hit Iranian air defences last year. Netanyahu has vowed less restraint since the unprecedented October 7, 2023 attack on Israel by Tehran-backed Hamas, which triggered the massive Israeli offensive in Gaza. The United States and other Western countries, along with Israel, have repeatedly accused Iran of seeking a nuclear weapon, which it has repeatedly denied. Israel again called for global action after the UN's International Atomic Energy Agency (IAEA) accused Iran on Wednesday of non-compliance with its obligations. The resolution could lay the groundwork for European countries to invoke a "snapback" mechanism, which expires in October, that would reinstate UN sanctions eased under a 2015 nuclear deal negotiated by then US president Barack Obama. Trump pulled out of the deal in his first term and slapped Iran with sweeping sanctions. Iran's nuclear chief, Mohammad Eslami, slammed the resolution as "extremist" and blamed Israeli influence. In response to the resolution, Iran said it would launch a new enrichment centre in a secure location. Iran would also replace "all of these first-generation machines with sixth-generation advanced machines" at the Fordo uranium enrichment plant, said Behrouz Kamalvandi, spokesman of the Atomic Energy Organization of Iran. Iran currently enriches uranium to 60 percent, far above the 3.67-percent limit set in the 2015 deal and close, though still short, of the 90 percent needed for a nuclear warhead. bur-hmn/tym
Yahoo
32 minutes ago
- Yahoo
China-to-US Freight Rates ‘No Longer Surging'—Is it All Downhill from Here?
After a series of weeks which saw trans-Pacific container prices double in the wake of a tariff truce between the U.S. and China, ocean freight rates may have already hit their summer seasonal peak. According to Hong Kong-based container shipping researcfh firm Linerlytica, rates have peaked after ocean carriers rolled back general rate increases (GRIs) from the previous two weeks as trans-Pacific capacity injections have still exceeded market demand. More from Sourcing Journal As Houthis Warn of 'War' Amid Israel-Iran Tensions, Red Sea Shipping Still Stagnant Trump Likely to Extend Tariff Pause as Negotiations Take Shape, Treasury Secretary Says Trump Touts Higher Duty Rate for Chinese Imports Under New Trade Deal A weekly update on Monday indicated that carriers are 'struggling to fill the ships' on the pathway to Los Angeles-Long Beach. Drewry's World Container Index (WCI), which saw ocean freight rates skyrocket 117 percent on the trans-Pacific trade lane in the four-week span prior to June 5, experienced a paltry 1 percent weekly jump to $5,914 per 40-foot container. The Shanghai-to-New York route had a major stabilization as well, shooting up 96 percent in a four-week span before inching up 2 percent to $7,285 per container. Overall, week-over-week totals across the WCI remained stable at $3,543 per 40-foot container. 'Global container shipping has addressed short-term capacity shortages and spot rates are now no longer surging, which will come as a relief to shippers,' said Philip Damas, head of Drewry Supply Chain Advisors. As carriers resumed suspended services and new carriers entered the market, Asia-to-West Coast ship capacity rose 16 percent month over month in June and is expected to increase another 8 percent in July, 'with far fewer cancelled sailings than in April/May,' Damas told Sourcing Journal. However, while GRI hikes are a lever ocean carriers often pull to capitalize on a surge in cargo and increase freight rates, the increased capacity forced them to pull back a week after taking effect. 'The June 1 GRI was fully implemented but failed to hold,' said Hua Joo Tan, co-founder of Linerlytica. 'Freight rates are dropping from their early June peak and will continue to fall back due to excess capacity as well as the absence of box shortages and port congestion. The mid-June GRI appears to be doomed for the same reasons.' According to a Thursday weekly update from Flexport, carriers have fully withdrawn planned June 15 GRIs for West Coast destinations. On the East and Gulf Coasts, GRIs remain in effect. Not everyone is anticipating such a quick fall, with Xeneta expecting an element of front-loading to still permeate throughout the original 90-day tariff rollback period. Xeneta's chief analyst, Peter Sand, said that 'mid-high' spot rates—rates paid by shippers in the 75th-highest percentile of the spot market—were the first batch that needed to get goods into the U.S. immediately and refill inventory. This cohort drove the sharpest rise in China-to-U.S. demand right after the rollback was announced May 12, he said. 'As we head into the second half of June, shippers benchmarking themselves against mid-low and average freight rates on the trans-Pacific headhaul will have to pay up as well,' Sand told Sourcing Journal. 'Still a tight market, but not tightening further to lift mid-high, as carriers are busy and soon done with bringing capacity back to the trans-Pacific trade lanes.' Adding onto the uncertainty is the U.S.-China tariff situation itself, which is still up in the air despite the Trump administration's insistence that there will be no more changes. Although representatives from the U.S. and China came to a new trade deal on Wednesday that establishes a combined duty rate of 55 percent on imports from China, there have been scant details surrounding the agreement. Additionally, neither Presidents Donald Trump or Xi Jinping have officially approved the deal. 'There are still a lot of moving parts on the tariff front and this is unlikely to be the end as far as China tariffs are concerned,' Tan told Sourcing Journal. 'The cargo volume trajectory will also depend on the rest of tariff discussions that are yet to be finalized.' This refers to the other 90-day deadline for U.S. trade partners that were recipients of the reciprocal tariffs. Treasury Secretary Scott Bessent said Wednesday it is 'highly likely' the July 9 deadline would be extended. But with these de-escalations occurring, rates are likely to go on a downward slope if demand for carrier space weakens. 'Looking ahead, the end of the 90-day tariff pause and the probable early end of the peak season are expected to cause another downcycle in demand, another need for ship capacity changes and another sharp fall in spot freight rates from July,' said Damas.
Yahoo
32 minutes ago
- Yahoo
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note
Viking Therapeutics, Inc. (VKTX) closed at $28.59 in the latest trading session, marking a -1.26% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.38%. On the other hand, the Dow registered a gain of 0.24%, and the technology-centric Nasdaq increased by 0.24%. Prior to today's trading, shares of the company had gained 8.96% outpaced the Medical sector's gain of 4.64% and the S&P 500's gain of 6.6%. The investment community will be paying close attention to the earnings performance of Viking Therapeutics, Inc. in its upcoming release. The company is expected to report EPS of -$0.44, down 120% from the prior-year quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.86 per share and revenue of $25 million, indicating changes of -84.16% and 0%, respectively, compared to the previous year. Investors should also note any recent changes to analyst estimates for Viking Therapeutics, Inc. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Right now, Viking Therapeutics, Inc. possesses a Zacks Rank of #3 (Hold). The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 74, which puts it in the top 31% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Viking Therapeutics, Inc. (VKTX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
